f2 computation (for pts > 85%) [Dissolution / BCS / IVIVC]

posted by jag009  – NJ, 2018-09-12 00:00 (743 d 11:23 ago) – Posting: # 19262
Views: 3,076

» » One question related to f2 computation... According to guidance you only include one pt after 85 % release. But for drugs that don't show plateau after 85% (ie; even at one pt after 85%, the curve is still climbing) you have to include addition points right?
» Where does that concept come from? And could you put more words to it?
» Also, I am thinking a plateau is something which is hard to debate in a purely measurable way.
» Muy confundido :confused:

NOT me! My boss said so... I was wondering too.
Does it matter if the drug is an ER or IR?


Complete thread:

 Admin contact
21,072 posts in 4,394 threads, 1,468 registered users;
online 3 (0 registered, 3 guests [including 2 identified bots]).
Forum time: Thursday 11:23 CEST (Europe/Vienna)

Enlightenment is man’s emergence from his self-imposed nonage
for which he himself was responsible.
Nonage is the inability to use one’s own intellect
without the direction of another.    Immanuel Kant

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz